File Download

There are no files associated with this item.

Supplementary

Conference Paper: Cost-effectiveness of population-based screening for colorectal cancer in Hong Kong Chinese

TitleCost-effectiveness of population-based screening for colorectal cancer in Hong Kong Chinese
Authors
Issue Date2007
PublisherInternational Health Economics Association.
Citation
iHEA 6th World Congress, 8-11 July 2007, Lund, p. 50 How to Cite?
AbstractBackground: Many Asian countries, including Hong Kong, have experienced an increase of two to four times in colorectal cancer (CRC) incidence during the past few decades. CRC has recently become the second leading cause of cancer-related mortality in Hong Kong after lung cancer. There has not been a systematic assessment of the cost-effectiveness of CRC screening in Asia. Objective: To assess the cost-effectiveness of alternative CRC screening strategies (i.e. FOBT, sigmoidoscopy, colonoscopy or combinations thereof at different intervals) in average-risk Hong Kong Chinese. Methods: We specify a state-transition Markov model which is modified from a previous US model that simulates the natural history of the adenoma-carcinoma sequence as a function of age, sex and other risk factors. The model also contains a screening component that allows for the detection and removal of adenomas and possibly an early diagnosis of CRC; and a treatment component for all persons diagnosed with CRC. This modified model reflects the clinical practice in Hong Kong. Data are from local hospitals and laboratories, clinical trials, prospective studies and other published literature. The stopping age (69 vs. 79 years) for the different CRC screening strategies are also explored. Main outcome measures are cancer incidence reduction, years of life saved (YLS), lifetime costs, and incremental cost-effectiveness ratios. Sensitivity analyses are performed to assess the stability of the results within the plausible ranges of uncertain parameters and to establish a set of epidemiologic threshold parameters for which the different types of CRC screening should be considered. Anticipated significance of findings: Results from the mathematical model which simulates clinical practice can use to inform clinical guidelines in Hong Kong. A set of epidemiologic threshold parameters for which the different types of CRC screening should be considered is also useful especially given the continuing upward trend of CRC incidence among many Asian countries.
DescriptionAbstract and presentation
Persistent Identifierhttp://hdl.handle.net/10722/98676

 

DC FieldValueLanguage
dc.contributor.authorWoo, PSen_HK
dc.contributor.authorCheung, TKen_HK
dc.contributor.authorKuntz, Ken_HK
dc.contributor.authorLam, Een_HK
dc.contributor.authorWong, Ben_HK
dc.contributor.authorLeung, GMen_HK
dc.date.accessioned2010-09-25T17:57:36Z-
dc.date.available2010-09-25T17:57:36Z-
dc.date.issued2007en_HK
dc.identifier.citationiHEA 6th World Congress, 8-11 July 2007, Lund, p. 50en_HK
dc.identifier.urihttp://hdl.handle.net/10722/98676-
dc.descriptionAbstract and presentation-
dc.description.abstractBackground: Many Asian countries, including Hong Kong, have experienced an increase of two to four times in colorectal cancer (CRC) incidence during the past few decades. CRC has recently become the second leading cause of cancer-related mortality in Hong Kong after lung cancer. There has not been a systematic assessment of the cost-effectiveness of CRC screening in Asia. Objective: To assess the cost-effectiveness of alternative CRC screening strategies (i.e. FOBT, sigmoidoscopy, colonoscopy or combinations thereof at different intervals) in average-risk Hong Kong Chinese. Methods: We specify a state-transition Markov model which is modified from a previous US model that simulates the natural history of the adenoma-carcinoma sequence as a function of age, sex and other risk factors. The model also contains a screening component that allows for the detection and removal of adenomas and possibly an early diagnosis of CRC; and a treatment component for all persons diagnosed with CRC. This modified model reflects the clinical practice in Hong Kong. Data are from local hospitals and laboratories, clinical trials, prospective studies and other published literature. The stopping age (69 vs. 79 years) for the different CRC screening strategies are also explored. Main outcome measures are cancer incidence reduction, years of life saved (YLS), lifetime costs, and incremental cost-effectiveness ratios. Sensitivity analyses are performed to assess the stability of the results within the plausible ranges of uncertain parameters and to establish a set of epidemiologic threshold parameters for which the different types of CRC screening should be considered. Anticipated significance of findings: Results from the mathematical model which simulates clinical practice can use to inform clinical guidelines in Hong Kong. A set of epidemiologic threshold parameters for which the different types of CRC screening should be considered is also useful especially given the continuing upward trend of CRC incidence among many Asian countries.-
dc.languageengen_HK
dc.publisherInternational Health Economics Association.en_HK
dc.relation.ispartofiHEA 6th World Congress, 8-11 July 2007, Lunden_HK
dc.titleCost-effectiveness of population-based screening for colorectal cancer in Hong Kong Chineseen_HK
dc.typeConference_Paperen_HK
dc.identifier.emailWoo, PS: ppswoo@hkucc.hku.hken_HK
dc.identifier.emailLeung, GM: gmleung@hku.hken_HK
dc.identifier.authorityLeung, GM=rp00460en_HK
dc.identifier.hkuros130467en_HK
dc.identifier.spage50en_HK

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats